13F data as of 2021-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

66516T203

FAQ

Who are the top institutional investors holding NORTHERN GENESIS ACQUISITION (NGA-U)?

Major stakeholders currently include Bank Of Montreal /can/ ($27.0K), Morgan Stanley ($18.0K), Tower Research Capital LLC (TRC) ($7.0K). Based on the latest 13F filings, there are a total of 6 tracked investment funds and institutions maintaining positions in NGA-U.

What is the overall institutional sentiment toward NGA-U recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $12.3M, driven by 2 managers accumulating shares while 7 reduced their exposure.

Which institutions have been selling or reducing their NGA-U positions?

In the latest period, 0 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $12.3M.

Are there any notable investors adding NGA-U to their portfolios?

Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $11.0K.